So they teamed up with Cornell nanoscientist Paul McEuen to create wireless light-powered microelectronic devices that can turn nearly any well plate into an array of teeny-tiny electrochemical ...

The U.S. will rebuild a stockpile of bird flu vaccines for poultry that match the strain of the virus circulating in ...

The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies.

Summit Therapeutics (SMMT) stock received a new buy rating from Truist based on its deal-forming prospects in oncology. Read ...

The Dow Jones Industrial Average is declining Wednesday morning with shares of Merck and Johnson & Johnson seeing the biggest losses for the price-weighted average. The Dow Dow Jo ...

The two suspected cases are both children aged seven and 14 years and were treated in the outpatient department of a private ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $101.02 which represents a slight increase of $1.30 or 1.30% from the prior close of $99.72. The stock opened at $100.13 and touched a ...

Speaking with Stat ahead of his exit, Robert Califf expressed concern about the potential for brain drain in government. Other news is on promising drugs for lung cancer patients, the upcoming J.P.

The dengue vaccine market is on track for robust growth, with increasing global awareness, governmental support, and ...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows ...

UBS analyst Trung Huynh lowered the firm’s price target on Merck (MRK) to $120 from $125 and keeps a Buy rating on the shares as part of a ...